JP2018536638A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536638A5
JP2018536638A5 JP2018519833A JP2018519833A JP2018536638A5 JP 2018536638 A5 JP2018536638 A5 JP 2018536638A5 JP 2018519833 A JP2018519833 A JP 2018519833A JP 2018519833 A JP2018519833 A JP 2018519833A JP 2018536638 A5 JP2018536638 A5 JP 2018536638A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
patient
formula
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018519833A
Other languages
English (en)
Japanese (ja)
Other versions
JP6885607B2 (ja
JP2018536638A (ja
Filing date
Publication date
Priority claimed from KR1020160131313A external-priority patent/KR101949451B1/ko
Application filed filed Critical
Priority claimed from PCT/KR2016/011434 external-priority patent/WO2017065495A2/ko
Publication of JP2018536638A publication Critical patent/JP2018536638A/ja
Publication of JP2018536638A5 publication Critical patent/JP2018536638A5/ja
Application granted granted Critical
Publication of JP6885607B2 publication Critical patent/JP6885607B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018519833A 2015-10-13 2016-10-12 炎症性腸疾患およびアトピー性皮膚炎の処置のための組成物 Expired - Fee Related JP6885607B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20150142929 2015-10-13
KR10-2015-0142929 2015-10-13
KR10-2016-0131313 2016-10-11
KR1020160131313A KR101949451B1 (ko) 2015-10-13 2016-10-11 염증성 장 질환 및 아토피 피부염 치료용 조성물
PCT/KR2016/011434 WO2017065495A2 (ko) 2015-10-13 2016-10-12 염증성 장 질환 및 아토피 피부염 치료용 조성물

Publications (3)

Publication Number Publication Date
JP2018536638A JP2018536638A (ja) 2018-12-13
JP2018536638A5 true JP2018536638A5 (https=) 2019-11-28
JP6885607B2 JP6885607B2 (ja) 2021-06-16

Family

ID=58705365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018519833A Expired - Fee Related JP6885607B2 (ja) 2015-10-13 2016-10-12 炎症性腸疾患およびアトピー性皮膚炎の処置のための組成物

Country Status (5)

Country Link
US (1) US10278931B2 (https=)
EP (1) EP3363783B1 (https=)
JP (1) JP6885607B2 (https=)
KR (2) KR101949451B1 (https=)
CN (1) CN108137490B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101949451B1 (ko) * 2015-10-13 2019-05-10 주식회사 이노파마스크린 염증성 장 질환 및 아토피 피부염 치료용 조성물
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
AU2019334202A1 (en) * 2018-09-06 2021-03-25 Innopharmascreen, Inc. Methods and compositions for treatment of asthma or parkinson's disease
CN114681438B (zh) * 2022-05-17 2024-03-19 中国医学科学院基础医学研究所 二甲双胍及其它含胍化合物在逆转Gal-10结晶趋势并缓解相关疾病中应用
CN119970807A (zh) * 2025-03-07 2025-05-13 中国人民解放军总医院第一医学中心 Tslp表达水平调节剂及治疗银屑病的药物和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291616B2 (en) * 2001-10-31 2007-11-06 Cell Therapeutics, Inc. Aryl triazines as LPAAT-β inhibitors and uses thereof
AU2003244132A1 (en) * 2002-07-02 2004-01-23 Genox Research, Inc. Method of examining allergic disaese and drug for treating the same
US20110263901A1 (en) 2008-01-23 2011-10-27 Dhananjay Govind Sathe Process of Preparation of Proguanil
CN102088956A (zh) * 2008-05-09 2011-06-08 托马有限公司 氯胍用于治疗皮肤/粘膜疾病
US9416098B2 (en) 2010-01-06 2016-08-16 Immunomet Therapeutics Inc. Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
US8796338B2 (en) * 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
EA033067B1 (ru) * 2012-01-06 2019-08-30 Элселикс Терапьютикс, Инк. Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения
WO2015026215A1 (ko) 2013-08-23 2015-02-26 가톨릭대학교 산학협력단 바이구아나이드 유도체 화합물을 유효성분으로 포함하는 면역질환 또는 염증질환의 예방 또는 치료용 약제학적 조성물
CA2946516C (en) 2014-04-29 2022-02-01 The Catholic University Of Korea Industry-Academic Cooperation Foundation Compound having immune disease treatment effect and use thereof
WO2015167243A1 (ko) * 2014-04-29 2015-11-05 가톨릭대학교 산학협력단 면역질환 치료효과를 갖는 신규한 화합물 및 이의 용도
KR102216701B1 (ko) 2014-11-20 2021-02-18 이뮤노메트테라퓨틱스 인코포레이티드 바이구아나이드 화합물 및 이의 용도
KR101949451B1 (ko) * 2015-10-13 2019-05-10 주식회사 이노파마스크린 염증성 장 질환 및 아토피 피부염 치료용 조성물

Similar Documents

Publication Publication Date Title
JP2018536638A5 (https=)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
NZ611628A (en) Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
FI3504187T3 (fi) Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten
JP2017528507A5 (https=)
HK1202776A1 (en) Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
JP2011225596A5 (https=)
JP2020524689A5 (https=)
RU2017114352A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
NZ600544A (en) Compositions and methods for the treatment of angiogenesis-related eye diseases
NZ605469A (en) Nalbuphine-based formulations and uses thereof
JP2017105861A5 (https=)
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
EP4700016A3 (en) Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
JP2020500864A5 (https=)
JP2016505050A5 (https=)
JP2019507786A5 (https=)
HRP20211488T1 (hr) Sastav i metoda za liječenje metaboličkih poremećaja
Makedonova et al. Studying clinical and pathomorphological changes in gingival tissues when applying platelet-rich autoplasma regenerative method
JP2019520407A5 (https=)
JP2019524889A5 (https=)
FI3448430T3 (fi) Asetyylikoleeniesteraasi-inhibiittorin ja idalopirdiinin käyttö Parkinsonin taudin potilaiden kaatumisten vähentämiseksi
PH12020500001A1 (en) Non-pulsatile prolonged-release betahistine oral solid compositions
JP2014162761A5 (https=)